<DOC>
	<DOCNO>NCT00206245</DOCNO>
	<brief_summary>The primary objective compare efficacy three dos AZD0865 ( 25 , 50 75 mg ) . The secondary objective compare efficacy three dos AZD0865 esomeprazole 40 mg evaluate safety tolerability AZD0865 .</brief_summary>
	<brief_title>A Dose-finding Phase IIb Study With AZD0865 Esomeprazole GERD Patients With Erosive Esophagitis .</brief_title>
	<detailed_description />
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Identification main symptom heartburn define burn feel behind breastbone . Have least 6month history heartburn least 4 day episodes heartburn least overall moderate intensity last 7 day prior visit 1 . Erosive esophagitis accord LA classification Grade A , B , C D , visit 1 endoscopy . Have provide Informed consent . Subjects current historical evidence follow condition exclude study : Esophageal stricture . Primary esophageal motility disorder ( ) , i.e . diffuse esophageal spasm , achalasia . Systemic Sclerosis ( scleroderma ) . Irritable Bowel Syndrome ( IBS ) , i.e . upper abdominal discomfort pain opinion Investigator likely due IBS fulfil two criterion : relieve defecation , associate change frequency stool , associate change form ( appearance ) stool . Inflammatory bowel disease . ZollingerEllison syndrome . Gastric ulcer , duodenal ulcer duodenal erosion within last 3 month Subjects ) history significant ii ) current significant unstable : Cardiovascular disease cardiac chest pain . Cerebrovascular disease , cerebral ischemia , infarction , haemorrhage , embolus . Diabetes mellitus . Stable diabetes control diet , oral agent insulin acceptable . Pulmonary , renal , pancreatic liver diseases serious disease judge investigator interfere evaluation current study . Malignant disease ( except minor superficial skin disease ) . Generalised bleeding disorder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>GERD erosive esophagitis</keyword>
</DOC>